コンジュゲートされたヘプシジン模倣物 - Protagonist Therapeutics, Incorporated

Title:

コンジュゲートされたヘプシジン模倣物

Document Type and Number:

Japanese Patent JP2023540679

Kind Code:

A

Abstract:

本発明は、改善されたインビボ半減期を有するヘプシジン類似体、及び関連する医薬組成物、並びにそれらを使用する方法を提供する。

More Like This:

JP2001500365	INDUSTRIAL APPLICABILITY INDUSTRIAL APPLICABILITY Inhibitor of interaction between P53 and MDM2
WO/2021/195508	TREGITOPE CONSTRUCTS USEFUL IN THE PREVENTION AND TREATMENT OF TYPE 1 DIABETES
JP2003532683	[Title of Invention] CXCR4 antagonist treatment of hematopoietic cells

Inventors:

Vaughn Gregory Thomas
Bhandari Ashok
Zhang Jie
frederic brians troy
smythe mark leslie
Taranath Roopa

Application Number:

JP2023505864A

Publication Date:

September 26, 2023

Filing Date:

July 28, 2021

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Protagonist Therapeutics, Incorporated

International Classes:

C07K7/08; A61K38/08; A61K38/10; A61K47/60; A61P7/00; A61P7/06; C07K7/06; C12N15/16; C12N15/63

Attorney, Agent or Firm:

Hatsushi Shimizu
Hirotaka Yamaguchi
Shun Jinbe
Ryuichi Inoue
Toshimitsu Sato
Kousuke Umemura
Koichi Niimi
Tomohiko Kobayashi
Hideki Kodera
Masato Ozeki
Maki Shioda
Kazuya Kawamoto

Previous Patent: Implants and systems for scarless mastopexy

Next Patent: Method for operating elastic mounting forming machines, especially press machines